Development of Next-Generation Peptide Binders Using In vitro Display Technologies and Their Potential Applications
Open Access
- 1 January 2013
- journal article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 224
- https://doi.org/10.3389/fimmu.2013.00224
Abstract
During the last decade, a variety of monoclonal antibodies have been developed and used as molecular targeting drugs in medical therapies. Although antibody drugs tend to have intense pharmacological activities and negligible side effects, several issues in their development and prescription remain to be resolved. Synthetic peptides with affinities and specificities for a desired target have received significant attention as alternatives to antibodies. In vitro display technologies are powerful methods for the selection of such peptides from combinatorial peptide libraries. Various types of peptide binders are being selected with such technologies for use in a wide range of fields from bioscience to medicine. This mini review article focuses on the current state of in vitro display selection of synthetic peptide binders and compares the selected peptides with natural peptides/proteins to provide a better understanding of the target affinities and inhibitory activities derived from their amino acid sequences and structural frameworks. The potential of synthetic peptide binders as alternatives to antibody drugs in therapeutic applications is also reviewed.This publication has 55 references indexed in Scilit:
- Polycyclic Peptide TherapeuticsChemMedChem, 2013
- Beyond natural antibodies: the power of in vitro display technologiesNature Biotechnology, 2011
- Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza TherapyJournal of Medicinal Chemistry, 2010
- Potent D-peptide inhibitors of HIV-1 entryProceedings of the National Academy of Sciences of the United States of America, 2007
- Ribosome display: selecting and evolving proteins in vitro that specifically bind to a targetNature Methods, 2007
- In vitro selection of Jun-associated proteins using mRNA displayNucleic Acids Research, 2004
- Antibody humanization: a case of the ‘Emperor’s new clothes’?Immunology Today, 2000
- Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinitiesBiochemistry, 1995
- Binding to Protein Targets of Peptidic Leads Discovered by Phage Display: Crystal Structures of Streptavidin-Bound Linear and Cyclic Peptide Ligands Containing the HPQ SequenceBiochemistry, 1995
- A new type of synthetic peptide library for identifying ligand-binding activityNature, 1991